Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
uniQure NV has a consensus price target of $43.27 based on the ratings of 17 analysts. The high is $95 issued by Guggenheim on September 25, 2025. The low is $9 issued by Cantor Fitzgerald on March 2, 2026. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Chardan Capital, and Goldman Sachs on May 6, 2026, April 30, 2026, and April 20, 2026, respectively. With an average price target of $32.33 between HC Wainwright & Co., Chardan Capital, and Goldman Sachs, there's an implied 19.31% upside for uniQure NV from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for uniQure (NASDAQ:QURE) was reported by HC Wainwright & Co. on May 6, 2026. The analyst firm set a price target for $50.00 expecting QURE to rise to within 12 months (a possible 88.54% upside). 44 analyst firms have reported ratings in the last year.
The latest analyst rating for uniQure (NASDAQ:QURE) was provided by HC Wainwright & Co., and uniQure maintained their buy rating.
The last upgrade for uniQure NV happened on March 11, 2026 when Mizuho raised their price target to $35. Mizuho previously had a neutral for uniQure NV.
The last downgrade for uniQure NV happened on March 3, 2026 when Wells Fargo changed their price target from $60 to $15 for uniQure NV.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of uniQure, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for uniQure was filed on May 6, 2026 so you should expect the next rating to be made available sometime around May 6, 2027.
While ratings are subjective and will change, the latest uniQure (QURE) rating was a maintained with a price target of $70.00 to $50.00. The current price uniQure (QURE) is trading at is $26.52, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 05/06/2026 | Buy Now | 84.5% | HC Wainwright & Co. | $70 → $50 | Maintains | Buy | Get Alert |
| 04/30/2026 | Buy Now | 36.53% | Chardan Capital | $31 → $37 | Maintains | Buy | Get Alert |
| 04/20/2026 | Buy Now | -63.1% | Goldman Sachs | $9 → $10 | Maintains | Neutral | Get Alert |
| 03/23/2026 | Buy Now | -7.75% | Barclays | $31 → $25 | Maintains | Equal-Weight | Get Alert |
| 03/11/2026 | Buy Now | 29.15% | Mizuho | $12 → $35 | Upgrade | Neutral → Outperform | Get Alert |
| 03/10/2026 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 03/09/2026 | Buy Now | 14.39% | Chardan Capital | $16 → $31 | Maintains | Buy | Get Alert |
| 03/09/2026 | Buy Now | 29.15% | RBC Capital | $11 → $35 | Upgrade | Sector Perform → Outperform | Get Alert |
| 03/09/2026 | Buy Now | 121.4% | Wells Fargo | $15 → $60 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/03/2026 | Buy Now | -66.79% | Goldman Sachs | $37 → $9 | Maintains | Neutral | Get Alert |
| 03/03/2026 | Buy Now | -44.65% | Wells Fargo | $60 → $15 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/03/2026 | Buy Now | -40.96% | Chardan Capital | $53 → $16 | Maintains | Buy | Get Alert |
| 03/03/2026 | Buy Now | -55.72% | Mizuho | $33 → $12 | Downgrade | Outperform → Neutral | Get Alert |
| 03/02/2026 | Buy Now | -66.79% | Cantor Fitzgerald | $55 → $9 | Upgrade | Overweight → Neutral | Get Alert |
| 02/24/2026 | Buy Now | — | Wolfe Research | — | Initiates | → Peer Perform | Get Alert |
| 02/10/2026 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 01/28/2026 | Buy Now | 14.39% | Barclays | → $31 | Initiates | → Equal-Weight | Get Alert |
| 12/11/2025 | Buy Now | 47.6% | Stifel | $50 → $40 | Maintains | Buy | Get Alert |
| 12/09/2025 | Buy Now | 21.77% | Mizuho | $60 → $33 | Maintains | Outperform | Get Alert |
| 12/04/2025 | Buy Now | 95.57% | Chardan Capital | $53 → $53 | Maintains | Buy | Get Alert |
| 11/12/2025 | Buy Now | 121.4% | Wells Fargo | $80 → $60 | Maintains | Overweight | Get Alert |
| 11/11/2025 | Buy Now | 95.57% | Chardan Capital | $53 → $53 | Maintains | Buy | Get Alert |
| 11/10/2025 | Buy Now | 121.4% | Leerink Partners | $68 → $60 | Maintains | Outperform | Get Alert |
| 11/04/2025 | Buy Now | 40.22% | Goldman Sachs | $56 → $38 | Maintains | Neutral | Get Alert |
| 11/04/2025 | Buy Now | 66.05% | RBC Capital | $65 → $45 | Maintains | Outperform | Get Alert |
| 11/04/2025 | Buy Now | — | William Blair | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/04/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $110 → $70 | Maintains | Buy | Get Alert |
| 11/03/2025 | Buy Now | 95.57% | Chardan Capital | $76 → $53 | Maintains | Buy | Get Alert |
| 10/06/2025 | Buy Now | 305.9% | HC Wainwright & Co. | $70 → $110 | Maintains | Buy | Get Alert |
| 10/02/2025 | Buy Now | 195.2% | Wells Fargo | $65 → $80 | Maintains | Overweight | Get Alert |
| 09/25/2025 | Buy Now | 106.64% | Goldman Sachs | $13 → $56 | Maintains | Neutral | Get Alert |
| 09/25/2025 | Buy Now | 121.4% | Mizuho | $30 → $60 | Maintains | Outperform | Get Alert |
| 09/25/2025 | Buy Now | 139.85% | Wells Fargo | $30 → $65 | Maintains | Overweight | Get Alert |
| 09/25/2025 | Buy Now | 250.55% | Guggenheim | $28 → $95 | Maintains | Buy | Get Alert |
| 09/25/2025 | Buy Now | 195.2% | Cantor Fitzgerald | $47 → $80 | Maintains | Overweight | Get Alert |
| 09/25/2025 | Buy Now | 180.44% | Chardan Capital | $35 → $76 | Maintains | Buy | Get Alert |
| 09/24/2025 | Buy Now | 139.85% | Stifel | $30 → $65 | Maintains | Buy | Get Alert |
| 09/24/2025 | Buy Now | 150.92% | Leerink Partners | $48 → $68 | Maintains | Outperform | Get Alert |
| 09/24/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 09/08/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 09/08/2025 | Buy Now | 29.15% | Chardan Capital | $35 → $35 | Maintains | Buy | Get Alert |
| 09/05/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 08/29/2025 | Buy Now | 29.15% | Chardan Capital | $35 → $35 | Maintains | Buy | Get Alert |
| 07/29/2025 | Buy Now | 29.15% | Chardan Capital | $38 → $35 | Maintains | Buy | Get Alert |
| 05/30/2025 | Buy Now | 40.22% | Chardan Capital | $38 → $38 | Maintains | Buy | Get Alert |
| 05/29/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2025 | Buy Now | 3.32% | Guggenheim | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2025 | Buy Now | 40.22% | Chardan Capital | $38 → $38 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 40.22% | Chardan Capital | $38 → $38 | Maintains | Buy | Get Alert |
| 04/21/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 40.22% | Chardan Capital | $27 → $38 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2025 | Buy Now | 10.7% | Wells Fargo | $35 → $30 | Maintains | Equal-Weight | Get Alert |
| 01/27/2025 | Buy Now | 158.3% | HC Wainwright & Co. | $25 → $70 | Maintains | Buy | Get Alert |
| 01/21/2025 | Buy Now | -11.44% | RBC Capital | $24 → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 12/19/2024 | Buy Now | -26.2% | Mizuho | $7 → $20 | Maintains | Neutral | Get Alert |
| 12/16/2024 | Buy Now | 18.08% | Stifel | $12 → $32 | Maintains | Buy | Get Alert |
| 12/12/2024 | Buy Now | -26.2% | Goldman Sachs | $9 → $20 | Maintains | Neutral | Get Alert |
| 12/11/2024 | Buy Now | 62.36% | Leerink Partners | $26 → $44 | Maintains | Outperform | Get Alert |
| 12/11/2024 | Buy Now | — | Guggenheim | — | Reiterates | Buy → Buy | Get Alert |
| 12/11/2024 | Buy Now | -26.2% | RBC Capital | $14 → $20 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | -7.75% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 12/10/2024 | Buy Now | 91.88% | Raymond James | $20 → $52 | Upgrade | Outperform → Strong Buy | Get Alert |
| 12/10/2024 | Buy Now | 114.02% | Cantor Fitzgerald | $28 → $58 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | -7.75% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2024 | Buy Now | -66.79% | Goldman Sachs | $10 → $9 | Maintains | Neutral | Get Alert |
| 11/06/2024 | Buy Now | -48.34% | RBC Capital | $16 → $14 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 3.32% | Cantor Fitzgerald | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 10/10/2024 | Buy Now | -26.2% | Raymond James | → $20 | Reinstates | → Outperform | Get Alert |
| 09/20/2024 | Buy Now | 3.32% | Cantor Fitzgerald | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 08/20/2024 | Buy Now | -7.75% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2024 | Buy Now | -63.1% | Goldman Sachs | $6 → $10 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | -11.44% | Cantor Fitzgerald | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 07/09/2024 | Buy Now | -7.75% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | -7.75% | HC Wainwright & Co. | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 05/08/2024 | Buy Now | -77.86% | Mizuho | $7 → $6 | Maintains | Neutral | Get Alert |
| 03/04/2024 | Buy Now | -74.17% | Mizuho | $10 → $7 | Maintains | Neutral | Get Alert |
| 03/01/2024 | Buy Now | -7.75% | HC Wainwright & Co. | $30 → $25 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | -70.48% | Goldman Sachs | $63 → $8 | Downgrade | Buy → Neutral | Get Alert |
| 01/19/2024 | Buy Now | 10.7% | HC Wainwright & Co. | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2024 | Buy Now | 3.32% | RBC Capital | $28 → $28 | Reiterates | Outperform → Outperform | Get Alert |
| 12/20/2023 | Buy Now | -22.51% | Cantor Fitzgerald | $21 → $21 | Reiterates | Overweight → Overweight | Get Alert |
| 12/19/2023 | Buy Now | -63.1% | Mizuho | → $10 | Downgrade | Buy → Neutral | Get Alert |
| 11/08/2023 | Buy Now | 132.47% | Goldman Sachs | $56 → $63 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 10.7% | HC Wainwright & Co. | $90 → $30 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 54.98% | RBC Capital | $47 → $42 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | 84.5% | Raymond James | $56 → $50 | Maintains | Outperform | Get Alert |
| 06/22/2023 | Buy Now | -0.37% | Chardan Capital | $45 → $27 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 232.1% | HC Wainwright & Co. | → $90 | Reiterates | Buy → Buy | Get Alert |